ARTHROSAMID INJECTION IN LONDON: A BREAKTHROUGH TREATMENT FOR KNEE PAIN WITHOUT SURGERY
For years, patients with chronic knee pain faced a stark choice: manage symptoms with painkillers and physiotherapy, or eventually progress to knee replacement surgery.
But a revolutionary new treatment is changing that conversation entirely.
Arthrosamid , an intra-articular hydrogel injection is offering patients in London long-lasting knee pain relief with no surgery, no downtime, and no compromises.
WHAT IS ARTHROSAMID?
Arthrosamid is a non-biodegradable polyacrylamide hydrogel (iPAAG) that is injected directly into the knee joint.
Unlike traditional hyaluronic acid (HA) injections which break down within weeks Arthrosamid is designed to integrate with the synovial tissue, providing a durable cushioning effect that can last for years.
Developed in Denmark and now available across leading private clinics in London, Arthrosamid has been the subject of multiple clinical trials demonstrating its safety and effectiveness in patients with mild to moderate knee osteoarthritis.
HOW DOES IT WORK?
When injected into the knee, Arthrosamid acts as a mechanical stabiliser within the joint, redistributing load and reducing friction between the cartilage surfaces.
Over time, it integrates with the synovial membrane, where it continues to provide cushioning and may help modulate the inflammatory environment within the joint.
The injection takes just minutes and is typically performed under ultrasound guidance to ensure precise placement.
WHO IS ARTHROSAMID FOR?
Arthrosamid is particularly suited for patients who:
- Have mild to moderate knee osteoarthritis
- Are not yet ready or suitable for knee replacement surgery
- Have tried other conservative treatments without long-lasting relief
- Wish to delay or avoid surgery
- Lead active lifestyles and need a fast recovery with minimal disruption
CLINICAL EVIDENCE
A pivotal randomised controlled trial (HOPEFUL-1) demonstrated statistically significant improvements in pain and function in knee osteoarthritis patients receiving Arthrosamid, with benefits sustained at 2-year follow-up.
Further studies continue to support its safety profile and durability compared to alternative injectable treatments.
WHAT TO EXPECT: THE LONDON ARTHROSAMID EXPERIENCE
At specialist orthopaedic clinics in London, the process is streamlined and patient-focused. After an initial consultation and diagnostic imaging to confirm suitability, the injection is performed as an outpatient procedure.
Most patients experience mild soreness for a few days before noticing gradual improvement in pain and mobility over the following 4-8 weeks.
There is typically no requirement for hospital admission, general anaesthesia, or extended recovery time.
A NEW CHAPTER IN KNEE PAIN MANAGEMENT
Arthrosamid represents a genuine step-change in how we treat knee osteoarthritis. For patients in London, access to this innovative therapy has never been easier.
If you're living with persistent knee pain, ask your orthopaedic consultant whether Arthrosamid could be the solution you've been waiting for.
Comments
Post a Comment